INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2013

Urinary PGE-M is associated with obesity, smoking, lung metastases, and breast cancer risk, suggesting utility as a cancer biomarker.

This commentary discusses the potential of inflammatory biomarkers in cancer risk prediction and disease progression. Morris and colleagues reported that urinary PGE-M was positively associated with obesity, smoking, and lung metastases in breast cancer patients. Additionally, Kim and colleagues identified a potential association between urinary PGE-M and breast cancer risk among postmenopausal women, supporting urinary PGE-M as a promising biomarker.

Shows an association, not proof of cause and effect.

Study type
Commentary / narrative review
Who was studied
Patients with breast cancer and postmenopausal women
What was measured
Cancer risk, disease progression, obesity, smoking, and lung metastases

THE PAPER

Urinary PGE-M: a promising cancer biomarker.

Wang D, DuBois RN. Cancer Prev Res (Phila), 2013.

PubMed 23636051 ↗DOI 10.1158/1940-6207.capr-13-0153 ↗

CancerWeight & appetite

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.